单细胞RNA测序与定量蛋白质组学揭示脓毒症预后相关的新型活性蛋白
本研究采集脓毒症患者(NS=26,SV=27)及对照(Con=16)外周血,用scRNA-seq评估细胞异质性,通过聚类注释识别细胞群,基因集变异分析检测通路改变,Viper算法估计单细胞水平蛋白活性,细胞通讯分析研究信号网络,DIA蛋白质组学鉴定差异表达蛋白并整合验证,再用meta与生存分析评估预后价值。在34,228个细胞、22,673个特征中识别出5个细胞簇和253个活性蛋白(DIA验证FC>2,P<0.05),发现4个具有预后意义的蛋白(SPI1、MEF2A、CBX3、UBTF)并映射到细胞图谱。通路分析显示NS组细胞凋亡与炎症反应通路显著改变,SV组DNA修复与细胞存活通路活性增高。结论认为这些发现将差异活性蛋白与患者预后相联系,推进了对脓毒症病理生理的理解。
要点
- 在34,228个细胞、22,673个特征中识别出5个细胞簇和253个活性蛋白,经DIA验证(FC>2,P<0.05)。
- 发现SPI1、MEF2A、CBX3、UBTF四个具有预后意义的蛋白,并映射到细胞图谱上。
- NS组细胞凋亡与炎症反应相关通路显著改变;SV组DNA修复与细胞存活通路活性增高。
- 研究纳入脓毒症患者NS=26、SV=27及对照Con=16,采集外周血进行多组学分析。
适用人群与场景
- 脓毒症患者(NS=26,SV=27)及对照(Con=16),采集外周血样本。
研究设计与关键结果
- 研究类型为多组学分析,纳入脓毒症患者NS=26、SV=27及对照Con=16,采集外周血。
- scRNA-seq在34,228个细胞、22,673个特征中识别出5个细胞簇和253个活性蛋白(Viper算法),并经DIA蛋白质组学验证(FC>2,P<0.05)。
- 发现4个具有预后意义的蛋白(SPI1、MEF2A、CBX3、UBTF),并映射到细胞图谱上。
- 基因集变异分析显示NS组细胞凋亡与炎症反应相关通路显著改变,SV组DNA修复与细胞存活通路活性增高。
- 预后价值通过meta分析与生存分析评估。
证据类型、等级与局限
- 证据类型:多组学分析研究(scRNA-seq、DIA蛋白质组学、Viper算法、基因集变异分析、细胞通讯分析、meta与生存分析)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Objective: To uncover critical active proteins influencing sepsis outcomes through multiomics analysis. Methods: This study collected peripheral blood from sepsis patients (NS = 26, SV = 27) and controls (Con = 16). Cellular heterogeneity was assessed using scRNA-seq. Cellular populations were identified through clustering and annotation. Gene set variation analysis was employed to detect pathway alterations in sepsis, while the Viper algorithm estimated protein activity at the single-cell level. Signaling networks were investigated via cell-cell communication analysis. Differentially expressed proteins were identified by DIA proteomics and confirmed through integrated analysis. Prognostic value was evaluated via meta and survival analyses. Results: scRNA-seq of 22,673 features within 34,228 cells identified five cellular clusters and 253 active proteins via Viper, validated by DIA (FC > 2, P < 0.05). Four proteins (SPI1, MEF2A, CBX3, UBTF) with prognostic significance were discovered and mapped onto the cellular landscape. Gene set variation analysis enrichment analysis revealed that the NS group exhibited significant alterations in pathways related to cellular apoptosis and inflammatory responses, while the SV group displayed increased activity in DNA repair and cellular survival pathways. Conclusion: The study's findings advance the understanding of sepsis pathophysiology by linking differentially active proteins to patient prognosis, paving the way for targeted therapeutic strategies.
参考来源
- Liu H, Xiong W, Zhong W, et al. NOVEL ACTIVE PROTEINS FOR SEPSIS PROGNOSIS REVEALED THROUGH ScRNA-seq AND QUANTITATIVE PROTEOMICS. Shock. 2024. PMID: 38888471. doi:10.1097/SHK.0000000000002408
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。